Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
134978-97-5
134978-99-7
195071-49-9
1350754-14-1
1155811-37-2
134979-01-4
869725-46-2 | 6-(Trifluoromethyl)-2,3-dihydro-1h-inden-1-ol | AA00IE7M | MFCD15529855
872365-04-3 | 2-Benzothiazolamine, 7-chloro-4-fluoro- | AA00IED9 | MFCD27976890
876343-09-8 | 4-Chloro-6-iodo-7-phenylsulfonyl-7h-pyrrolo[2,3-d]pyrimidine | AA00IEML | MFCD17015878
881189-58-8 | 3-(5-bromo-2-fluorophenyl)propanoic acid | AA00IEWL | MFCD11036289
885519-36-8 | 3-Bromo-1h-indazol-5-ol | AA00IF3N | MFCD07781664
886762-28-3 | 2-Chloro-4-(trifluoromethyl)nicotinamide | AA00IF8P | MFCD04039215
889768-55-2 | 3,5-Dichloro-4-ethoxypyridazine | AA00IFG8 | MFCD14582884
896906-11-9 | 4-(Chloromethyl)-N-cyclopentylbenzamide | AA00IFPZ | MFCD02826241
900152-50-3 | Methyl 1-[(4-methoxyphenyl)methyl]pyrrole-2-carboxylate | AA00IFVZ | MFCD22383700
90526-00-4 | 2,3-Dichloro-N,N-dimethylbenzamide | AA00IG3A | MFCD20355187